牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Executive Vice President Lidia Fonseca was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report confirms Fonseca's continued relationship with Pfizer as an executive officer but does not offer insight into her remaining shareholdings following the transaction.
Pfizer Inc. (PFE) Executive Vice President Lidia Fonseca was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report confirms Fonseca's continued relationship with Pfizer as an executive officer but does not offer insight into her remaining shareholdings following the transaction.
據報道，輝瑞公司（PFE）執行副總裁莉迪亞·豐塞卡於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。該報告證實了豐塞卡作爲執行官與輝瑞的持續關係，但沒有透露她在交易後的剩餘股權。
據報道，輝瑞公司（PFE）執行副總裁莉迪亞·豐塞卡於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。該報告證實了豐塞卡作爲執行官與輝瑞的持續關係，但沒有透露她在交易後的剩餘股權。
有用
沒用